Patent Assignment
Reel/Frame 075813/0266
Assignment of Assignor's Interest
Recorded: 2026-06-24
Pages: 31
Assignor
ADAPTIMMUNE LIMITED
Executed: 2025-03-21
Assignee
IMMUNOCORE LIMITED
92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4RY, UNITED KINGDOM
Covered Properties
(73)
Cells Expressing a Modified T Cell Receptor
Method of Improving T Cell Receptors
Cells Expressing Modified T Cell Receptor
Tcr Libraries
Application:
15/262,160 →
Publication:
US US20170051036A1
Tcr Libraries
Peptides Derived from Actin-Like Protein 8 (ACTL8)
Peptides
Application:
15/777,149 →
Publication:
US US20180327466A1
Peptides Derived from Kita-Kyushu Lung Cancer Antigen (KKLC1, CT83, CXORF61) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Peptides Derived from Kallikrein 4
Application:
15/777,155 →
Publication:
US US20180334663A1
Peptides Derived from Achaete-Scute Homolog 2 (ASCL2), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/777,163 →
Publication:
US US20180355006A1
Peptides
Application:
15/777,180 →
Publication:
US US20180334476A1
Peptides Derived from Prostate Specific Antigen (KLK3) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/777,613 →
Publication:
US US20180339028A1
Peptides Derived from Lengsin (Lgsn), Complexes Comprising Such Peptides Bound to Mhc Molecules
Peptides
Application:
15/777,629 →
Publication:
US US20180334485A1
Peptides
Application:
15/777,874 →
Publication:
US US20180346514A1
Peptides Derived from Homeobox Protein B13 (Hox-B13) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/777,875 →
Publication:
US US20180339029A1
Peptides
Application:
15/777,877 →
Publication:
US US20180346545A1
Peptides from NPSR1
Application:
15/777,880 →
Publication:
US US20180339027A1
Peptides
Application:
15/777,882 →
Publication:
US US20180371039A1
Peptides Derived from Melanoma-Associated Antigen C2 (MAGEC2) and Uses Thereof
Application:
15/777,883 →
Publication:
US US20180346511A1
Peptides
Application:
15/777,885 →
Publication:
US US20180346546A1
Peptides Derived from P Antigen Family Member 2 (PAGE2)
Application:
15/777,888 →
Publication:
US US20180346547A1
Peptides of PAGE5
Application:
15/777,892 →
Publication:
US US20180371040A1
Peptides from PIWIL1
Application:
15/778,175 →
Publication:
US US20180346515A1
Peptides Derived from Prorelaxin H1 (RLN1)
Application:
15/778,177 →
Publication:
US US20180340016A1
Peptides Derived from Sarcoma Antigen 1 (SAGE1) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
15/778,179 →
Publication:
US US20180346536A1
Peptides
Application:
15/778,198 →
Publication:
US US20180346575A1
Peptides Derived from Solute Carrier Family 45 Member 2 (SLC45A2) and Uses Thereof
Application:
15/778,199 →
Publication:
US US20180346517A1
Peptides
Application:
15/778,204 →
Publication:
US US20180340018A1
Peptides Derived from Transient Receptor Potential Cation Channel Subfamily M Member 1 (TRPM1), Complexes Comprising Such Peptides Bound to Mhc Molecules
Peptides
Application:
16/084,883 →
Publication:
US US20190083591A1
Peptides of Bromodomain Testis-Specific Protein (Brdt)
Application:
16/097,582 →
Publication:
US US20190153053A1
Claudin-6 Peptides
Application:
16/097,587 →
Publication:
US US20190161528A1
Peptides
Application:
16/347,384 →
Publication:
US US20210115099A1
Peptides
Application:
16/938,263 →
Publication:
US US20210054080A1
Peptides Derived from P Antigen Family Member 2 (PAGE2)
Application:
16/985,058 →
Publication:
US US20210017250A1
Peptides
Application:
16/985,061 →
Publication:
US US20210017227A1
Peptides
Application:
16/988,425 →
Publication:
US US20210032301A1
Peptides
Application:
16/988,431 →
Publication:
US US20210017228A1
Peptides Derived from Transient Receptor Potential Cation Channel Subfamily M Member 1 (TRPM1), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
16/988,523 →
Publication:
US US20220175949A9
Peptides from PIWIL1
Application:
16/994,399 →
Publication:
US US20210061857A1
Peptides Derived from Kallikrein 4
Application:
16/998,945 →
Publication:
US US20210047629A1
Peptides
Application:
17/010,653 →
Publication:
US US20210054045A1
Peptides
Application:
17/013,228 →
Publication:
US US20210054036A1
Claudin-6 Peptides
Application:
17/017,444 →
Publication:
US US20210061874A1
Peptides of PAGE5
Application:
17/017,457 →
Publication:
US US20210054037A1
Peptides of Bromodomain Testis-Specific Protein (Brdt)
Application:
17/031,691 →
Publication:
US US20210101949A1
Peptides Derived from Kita-Kyushu Lung Cancer Antigen (KKLC1, CT83, CXORF61) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/065,509 →
Publication:
US US20210121526A1
Peptides Derived from Lengsin (Lgsn), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/083,158 →
Publication:
US US20210123037A1
Peptides
Application:
17/087,363 →
Publication:
US US20210122794A1
Peptides Derived from Melanoma-Associated Antigen C2 (MAGEC2) and Uses Thereof
Application:
17/092,691 →
Publication:
US US20210121551A1
Progesterone-Associated Endometrial Protein (Paep) and Uses Thereof
Application:
17/092,715 →
Publication:
US US20210121547A1
Peptides Derived from Solute Carrier Family 45 Member 2 (SLC45A2) and Uses Thereof
Application:
17/092,970 →
Publication:
US US20210122784A1
Peptides Derived from Achaete-Scute Homolog 2 (ASCL2), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/099,242 →
Publication:
US US20210122798A1
Peptides Derived from Prorelaxin H1 (RLN1)
Application:
17/099,267 →
Publication:
US US20210147505A1
Peptides
Application:
17/099,286 →
Publication:
US US20210122803A1
Peptides Derived from Prostate Specific Antigen (KLK3) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/104,415 →
Publication:
US US20210138054A1
Peptides
Application:
17/104,668 →
Publication:
US US20210139558A1
Peptides Derived from Homeobox Protein B13 (Hox-B13) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/104,677 →
Publication:
US US20210170003A1
Peptides Derived from Sarcoma Antigen 1 (SAGE1 ) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
17/105,010 →
Publication:
US US20210171594A1
Peptides from NPSR1
Application:
17/243,932 →
Publication:
US US20210322528A1
Tcr Libraries
Application:
17/334,469 →
Publication:
US US20210371493A1
Tcr Libraries
Peptides
Application:
17/811,040 →
Peptides Derived from Actin-Like Protein 8 (ACTL8)
Application:
17/831,193 →
Progesterone-Associated Endometrial Protein (Paep) and Uses Thereof
Application:
17/938,323 →
Peptides Derived from Melanoma-Associated Antigen C2 (MAGEC2) and Uses Thereof
Application:
17/948,146 →
Publication:
US US20230190901A1
Peptides Derived from Solute Carrier Family 45 Member 2 (SLC45A2) and Uses Thereof
Application:
17/963,988 →
Peptides Derived from Transient Receptor Potential Cation Channel Subfamily M Member 1 (TRPM1), Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
18/046,148 →
Peptides Derived from Actin-Like Protein 8 (ACTL8)
Application:
18/049,198 →
Peptides
Application:
18/064,180 →
Publication:
US US20230346885A1
Peptides Derived from Kita-Kyushu Lung Cancer Antigen (KKLC1, CT83, CXORF61) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
18/149,664 →
Publication:
US US20230330181A1
Peptides Derived from Kita-Kyushu Lung Cancer Antigen (KKLC1, CT83, CXORF61) and Complexes Comprising Such Peptides Bound to Mhc Molecules
Application:
18/908,671 →
Publication:
US US20250134956A1
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 30, 2008
From: DUNN, STEVEN MARK; LI, YI; BOULTER, JONATHAN MICHAEL
To: MEDIGENE LIMITED
Reel/Frame 021765/0573 →
Assignment of Assignor's Interest
Jan 8, 2009
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 022076/0044 →
Assignment of Assignor's Interest
Apr 13, 2009
From: JAKOBSEN, BENT KARSTEN
To: IMMUNOCORE LIMITED
Reel/Frame 022538/0727 →
Assignment of Assignor's Interest
Jul 9, 2009
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 022934/0471 →
Assignment of Assignor's Interest
Dec 17, 2012
From: JAKOBSEN, BENT KARSTEN
To: IMMUNOCORE LIMITED
Reel/Frame 029482/0432 →
Assignment of Assignor's Interest
Jul 18, 2013
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED; IMMUNOCORE LIMITED
Reel/Frame 030824/0150 →
Assignment of Assignor's Interest
Jul 18, 2013
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED; IMMUNOCORE LIMITED
Reel/Frame 030824/0190 →
Assignment of Assignor's Interest
Nov 8, 2016
From: JAKOBSEN, BENT KARSTEN; MOLLOY, PETER EAMON; VUIDEPOT, ANNELISE BRIGITTE; LIDDY, NATHANIEL ROSS
To: IMMUNOCORE LIMITED; ADAPTIMMUNE LIMITED
Reel/Frame 040255/0741 →
Assignment of Assignor's Interest
Apr 15, 2019
From: JAKOBSEN, BENT KARSTEN; LIDDY, NATHANIEL ROSS; MOLLOY, PETER EAMON; VUIDEPOT, ANNELISE BRIGITTE
To: IMMUNOCORE LIMITED
Reel/Frame 048884/0814 →
Assignment of Assignor's Interest
Apr 15, 2019
From: POPA, ALINA; POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 048888/0758 →
Assignment of Assignor's Interest
Apr 15, 2019
From: POWLESLAND, ALEX; KLEIJNEN, MAURITS
To: IMMUNOCORE LIMITED
Reel/Frame 048888/0879 →
Assignment of Assignor's Interest
Apr 15, 2019
From: CHESTER, FIONA; POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 048888/0986 →
Assignment of Assignor's Interest
Apr 15, 2019
From: CHESTER, FIONA; POPA, ALINA; POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 048888/0529 →
Assignment of Assignor's Interest
Sep 6, 2019
From: POWLESLAND, ALEX; POPA, ALINA
To: IMMUNOCORE LIMITED
Reel/Frame 050299/0136 →
Assignment of Assignor's Interest
Sep 6, 2019
From: POWLESLAND, ALEX; CHILLAKURI, CHANDRAMOULI; SANGANI, DHAVAL; OESTRINGER, BENJAMIN
To: IMMUNOCORE LIMITED
Reel/Frame 050299/0231 →
Assignment of Assignor's Interest
Sep 6, 2019
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 050299/0201 →
Assignment of Assignor's Interest
Sep 6, 2019
From: POWLESLAND, ALEX; CHILLAKURI, CHANDRAMOULI; SANGANI, DHAVAL; POPA, ALINA
To: IMMUNOCORE LIMITED
Reel/Frame 050299/0107 →
Assignment of Assignor's Interest
Sep 6, 2019
From: POWLESLAND, ALEX; PENTIER, JOHANNE; GALFRE, ELENA
To: IMMUNOCORE LIMITED
Reel/Frame 050299/0068 →
Assignment of Assignor's Interest
Sep 6, 2019
From: POWLESLAND, ALEX; CHESTER, FIONA; DELLACRISTINA, PIETRO; CHILLAKURI, CHANDRAMOULI
To: IMMUNOCORE LIMITED
Reel/Frame 050299/0172 →
Assignment of Assignor's Interest
Oct 2, 2019
From: ADDIS, PHILIP
To: IMMUNOCORE LIMITED
Reel/Frame 050598/0888 →
Assignment of Assignor's Interest
Dec 3, 2019
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 051167/0596 →
Assignment of Assignor's Interest
Dec 3, 2019
From: POWLESLAND, ALEX; DE SOUZA, VICTORIA ARENA; CHILLAKURI, CHANDRAMOULI; SANGANI, DHAVAL
To: IMMUNOCORE LIMITED
Reel/Frame 051167/0555 →
Assignment of Assignor's Interest
Dec 13, 2019
From: POWLESLAND, ALEX
To: IMMUNOCORE LIMITED
Reel/Frame 051281/0767 →
Assignment of Assignor's Interest
Feb 27, 2020
From: HOOD, GRAHAM
To: IMMUNOCORE LIMITED
Reel/Frame 051954/0750 →
Assignment of Assignor's Interest
Feb 27, 2020
From: HOOD, GRAHAM
To: IMMUNOCORE LIMITED
Reel/Frame 051954/0414 →